FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:7-14 January 6, 1994 Number 1 Next

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Among patients with the idiopathic nephrotic syndrome who have focal and segmental glomerulosclerosis and undergo renal transplantation, 15 to 55 percent have recurrent nephrotic syndrome. The recurrence may be caused by a plasma factor or factors that increase glomerular permeability, because plasma exchange transiently decreases or abolishes proteinuria in some patients. We studied the effect on proteinuria of the removal of protein (mostly immunoglobulins) by adsorption onto protein A from the plasma of patients with recurrent nephrotic syndrome.

Methods Eight patients were treated with one to three cycles of two to seven 1-day sessions of protein adsorption, and the patients' urinary protein excretion was measured repeatedly. Their immunosuppressive regimens were not changed during the treatment. The adsorbed proteins were eluted from the protein A and injected into rats, and the urinary albumin excretion of the rats was measured.

Results The protein-adsorption treatment consistently decreased urinary protein excretion by an average of 82 percent at the end of a cycle (P<0.001). In one patient proteinuria disappeared, and in another urinary protein excretion remained below 2.5 g per day with repeated cycles of protein adsorption. In all but one patient the effect of adsorption was limited in time, with a return to the preadsorption level of protein excretion within a maximum of two months. The administration to rats of material eluted from the protein A increased urinary albumin excretion 2.9- to 4.6-fold (P<0.001 and P = 0.005, respectively). Although protein A primarily binds immunoglobulins, the active fraction of the eluted proteins had a molecular weight below 100,000, indicating that immunoglobulin was not directly involved.

Conclusions Adsorption of plasma protein decreases urinary protein excretion in patients with recurrence of the nephrotic syndrome after renal transplantation. Studies of the adsorbed proteins should provide information about the mechanism of this disease.

Source Information

From the Service de Nephrologie-Immunologie Clinique (J.D., A.T., J.P.S.), and INSERM U.211 (Unite de Recherche sur les Effecteurs Lymphocytaires T) (J.D., E.B., W.B., Y.J., J.P.S.), Centre hospitalier regional et universitaire (C.H.R.U.), Nantes; the Service de Nephrologie, Hopital de Bicetre, Le Kremlin Bicetre (F.K., B.C.); the Service de Nephrologie Pediatrique, Hopital Necker Enfants Malades, Paris (P.N.); and the Service de Nephrologie, C.H.R.U. Clemenceau, Caen (B.H.L.) -- all in France.

Address reprint requests to Dr. Dantal at the Service de Nephrologie-Immunologie Clinique, C.H.R.U., Pl. Alexis Ricordeau, 44035 Nantes CEDEX, France.

Full Text of this Article

This article has been cited by other articles:

• Xin, Z., Zhihong, L., Shijun, L., Jinfeng, Z., Huiping, C., Caihong, Z., Daxi, J., Leishi, L. (2008). Successful treatment of patients with lipoprotein glomerulopathy by protein A immunoadsorption: a pilot study. Nephrol Dial Transplant 0: gfn555v1-gfn555 [Abstract] [Full Text]  
• Coppo, R. (2008). Non-steroidal and non-cytotoxic therapies for nephrotic syndrome. Nephrol Dial Transplant 23: 1793-1796 [Full Text]  
• Kausman, J. Y., Kitching, A. R. (2007). A New Approach to Idiopathic Nephrotic Syndrome. J. Am. Soc. Nephrol. 18: 2621-2622 [Full Text]  
• Musante, L., Candiano, G., Petretto, A., Bruschi, M., Dimasi, N., Caridi, G., Pavone, B., Del Boccio, P., Galliano, M., Urbani, A., Scolari, F., Vincenti, F., Ghiggeri, G. M. (2007). Active Focal Segmental Glomerulosclerosis Is Associated with Massive Oxidation of Plasma Albumin. J. Am. Soc. Nephrol. 18: 799-810 [Abstract] [Full Text]  
• Kiselyov, K., Soyombo, A., Muallem, S. (2007). TRPpathies. J. Physiol. 578: 641-653 [Abstract] [Full Text]  
• Brukamp, K., Doyle, A. M., Bloom, R. D., Bunin, N., Tomaszewski, J. E., Cizman, B. (2006). Nephrotic Syndrome after Hematopoietic Cell Transplantation: Do Glomerular Lesions Represent Renal Graft-versus-Host Disease?. CJASN 1: 685-694 [Abstract] [Full Text]  
• Pardon, A., Audard, V., Caillard, S., Moulin, B., Desvaux, D., Bentaarit, B., Remy, P., Sahali, D., Roudot-Thoraval, F., Lang, P., Grimbert, P. (2006). Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 21: 1053-1059 [Abstract] [Full Text]  
• Herve, C., Dantal, J. (2006). Possible new perspectives for our understanding of nephrotic syndrome recurrence. Nephrol Dial Transplant 21: 10-13 [Full Text]  
• Meyrier, A. (2004). Nephrotic focal segmental glomerulosclerosis in 2004: an update. Nephrol Dial Transplant 19: 2437-2444 [Full Text]  
• Carraro, M., Zennaro, C., Artero, M., Candiano, G., Ghiggeri, G. M., Musante, L., Sirch, C., Bruschi, M., Faccini, L. (2004). The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis. Nephrol Dial Transplant 19: 1969-1975 [Abstract] [Full Text]  
• Ghiggeri, G. M., Carraro, M., Vincenti, F. (2004). Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy. Nephrol Dial Transplant 19: 1036-1040 [Full Text]  
• Floege, J. (2003). Recurrent glomerulonephritis following renal transplantation: an update. Nephrol Dial Transplant 18: 1260-1265 [Full Text]  
• Carraro, M., Zennaro, C., Candiano, G., Musante, L., Bruschi, M., Ghiggeri, G. M., Artero, M., Faccini, L. (2003). Nephrotic urine prevents increased rat glomerular albumin permeability induced by serum from the same patient with idiopathic nephrotic syndrome. Nephrol Dial Transplant 18: 689-693 [Abstract] [Full Text]  
• Cattran, D., Neogi, T., Sharma, R., McCarthy, E. T., Savin, V. J. (2003). Serial Estimates of Serum Permeability Activity and Clinical Correlates in Patients with Native Kidney Focal Segmental Glomerulosclerosis. J. Am. Soc. Nephrol. 14: 448-453 [Abstract] [Full Text]  
• Glassock, R. J. (2003). Circulating Permeability Factors in the Nephrotic Syndrome: A Fresh Look at an Old Problem. J. Am. Soc. Nephrol. 14: 541-543 [Full Text]  
• Carraro, M., Caridi, G., Bruschi, M., Artero, M., Bertelli, R., Zennaro, C., Musante, L., Candiano, G., Perfumo, F., Ghiggeri, G. M. (2002). Serum Glomerular Permeability Activity in Patients with Podocin Mutations (NPHS2) and Steroid-ResistantNephrotic Syndrome. J. Am. Soc. Nephrol. 13: 1946-1952 [Abstract] [Full Text]  
• Bussemaker, E., Passauer, J., Franz, T., Gross, P. (2001). Tryptophan immunoadsorption strongly reduces proteinuria in recurrent nephrotic syndrome. Nephrol Dial Transplant 16: 1270-1272 [Full Text]  
• Ghiggeri, G. M., Artero, M., Carraro, M., Perfumo, F. (2001). Permeability plasma factors in nephrotic syndrome: more than one factor, more than one inhibitor. Nephrol Dial Transplant 16: 882-885 [Full Text]  
• Schmaldienst, S., Mullner, M., Goldammer, A., Spitzauer, S., Banyai, S., Horl, W. H., Derfler, K. (2001). Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases?. Rheumatology (Oxford) 40: 513-521 [Abstract] [Full Text]  
• SCHWARZ, A. (2001). New Aspects of the Treatment of Nephrotic Syndrome. J. Am. Soc. Nephrol. 12: 44S-47 [Abstract] [Full Text]  
• CANDIANO, G., MUSANTE, L., CARRARO, M., FACCINI, L., CAMPANACCI, L., ZENNARO, C., ARTERO, M., GINEVRI, F., PERFUMO, F., GUSMANO, R., GHIGGERI, G. M. (2001). Apolipoproteins Prevent Glomerular Albumin Permeability Induced In Vitro by Serum from Patients with Focal Segmental Glomerulosclerosis. J. Am. Soc. Nephrol. 12: 143-150 [Abstract] [Full Text]  
• Andresdottir, M. B., Ajubi, N., Croockewit, S., Assmann, K. J. M., Hibrands, L. B., Wetzels, J. F. M. (1999). Recurrent focal glomerulosclerosis: natural course and treatment with plasma exchange. Nephrol Dial Transplant 14: 2650-2656 [Abstract] [Full Text]  
• ESNAULT, V. L. M., BESNIER, D., TESTA, A., COVILLE, P., SIMON, P., SUBRA, J.-F., AUDRAIN, M. A. P. (1999). Effect of Protein A Immunoadsorption in Nephrotic Syndrome of Various Etiologies. J. Am. Soc. Nephrol. 10: 2014-2017 [Abstract] [Full Text]  
• CHEUNG, P. K., STULP, B., IMMENSCHUH, S., BORGHUIS, T., BALLER, J. F. W., BAKKER, W. W. (1999). Is 100KF an Isoform of Hemopexin? Immunochemical Characterization of the Vasoactive Plasma Factor 100KF. J. Am. Soc. Nephrol. 10: 1700-1708 [Abstract] [Full Text]  
• Binder, C. J., Weiher, H., Exner, M., Kerjaschki, D. (1999). Glomerular Overproduction of Oxygen Radicals in Mpv17 Gene-Inactivated Mice Causes Podocyte Foot Process Flattening and Proteinuria : A Model of Steroid-Resistant Nephrosis Sensitive to RadicalScavenger Therapy. Am. J. Pathol. 154: 1067-1075 [Abstract] [Full Text]  
• SHARMA, M., SHARMA, R., MCCARTHY, E. T., SAVIN, V. J. (1999). "The FSGS Factor": Enrichment and in Vivo Effectof Activity from Focal Segmental Glomerulosclerosis Plasma. J. Am. Soc. Nephrol. 10: 552-561 [Abstract] [Full Text]  
• Orth, S. R., Ritz, E. (1998). The Nephrotic Syndrome. NEJM 338: 1202-1211 [Full Text]  
• Savin, V. J., Sharma, R., Sharma, M., McCarthy, E. T., Swan, S. K., Ellis, E., Lovell, H., Warady, B., Gunwar, S., Chonko, A. M., Artero, M., Vincenti, F. (1996). Circulating Factor Associated with Increased Glomerular Permeability to Albumin in Recurrent Focal Segmental Glomerulosclerosis. NEJM 334: 878-883 [Abstract] [Full Text]  
• Lesavre, P., Grunfeld, J.-P. (1996). Idiopathic Focal Segmental Glomerulosclerosis -- New Lessons from Kidney Transplantation. NEJM 334: 914-915 [Full Text]  
• Suthanthiran, M., Strom, T. B. (1994). Renal Transplantation. NEJM 331: 365-376 [Full Text]  
• Ritz, E. (1994). Pathogenesis of "Idiopathic" Nephrotic Syndrome. NEJM 330: 61-62 [Full Text]